股票 › MDXG
美迈德生物 MDXG
美股市值排名 #3671
$3.31 +$0.03 (+0.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.31 0.00%
开盘$3.25
昨收$3.28
当日区间$3.23 – $3.39
成交量1.11M
市值$483.01M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$62.28M-45.2% YoY
营业利润-$11.70M-152.7% YoY
净利润-$8.68M-151.8% YoY
摊薄每股收益-$0.06-154.5% YoY
自由现金流-$1.14M-104.5% YoY
经营现金流$3.92M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率77.3%
营业利润率-8.3%
净利率-6.3%
净资产收益率-8.5%
资产收益率-6.6%
投入资本回报率-8.5%
流动比率4.35
负债/资产比率20.2%
现金及投资$120.79M
净现金（净负债）$120.79M
自由现金流/营收5.9%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $62.28M | $64.36M | $58.99M | $418.63M | $118.10M |
| 营业总收入 | $62.28M | $64.36M | $58.99M | $418.63M | $118.10M |
| 营业成本 | $12.58M | $19.98M | $17.37M | $73.01M | $19.06M |
| 毛利润 | $49.70M | $44.38M | $41.62M | $345.62M | $99.04M |
| 营业费用 | $61.40M | $62.85M | $57.67M | $281.73M | $77.96M |
| 销售及管理费用 | $58.31M | $59.78M | $53.23M | $266.19M | $73.07M |
| -销售及营销费用 | $39.60M | $46.42M | $43.91M | – | – |
| -管理费用 | $18.71M | $13.36M | $9.32M | – | – |
| 研发费用 | $2.80M | $2.78M | $4.14M | $15.10M | $4.76M |
| 折旧、摊销与折耗 | $295,000.00 | $291,000.00 | $301,000.00 | $439,000.00 | $129,000.00 |
| -折旧与摊销 | $295,000.00 | $291,000.00 | $301,000.00 | $439,000.00 | $129,000.00 |
| 营业利润 | -$11.70M | -$18.47M | -$16.05M | $63.89M | $21.08M |
| 非经营性利息净收入（支出） | $776,000.00 | $788,000.00 | $886,000.00 | $2.93M | $904,000.00 |
| 非经营性利息收入 | $986,000.00 | – | $1.29M | – | – |
| 非经营性利息支出 | $210,000.00 | – | $402,000.00 | – | – |
| 其他收入（支出） | -$136,000.00 | -$102,000.00 | -$168,000.00 | -$558,000.00 | -$186,000.00 |
| 其他非经营性收入（支出） | -$136,000.00 | -$102,000.00 | -$168,000.00 | -$558,000.00 | -$186,000.00 |
| 税前利润 | -$11.06M | -$17.78M | -$15.33M | $66.26M | $21.80M |
| 税费 | -$2.38M | -$2.94M | -$4.47M | $17.68M | $6.60M |
| 净利润 | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| 持续经营利润 | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| 归属母公司净利润 | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| 归属普通股股东净利润 | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| 基本每股收益 | -$0.06 | -$0.10 | -$0.07 | $0.33 | $0.10 |
| 摊薄每股收益 | -$0.06 | -$0.10 | -$0.07 | $0.32 | $0.10 |
| 其他财务成本合计 | – | -$788,000.00 | – | -$2.93M | – |
| 特殊收益（费用） | – | – | – | $0.00 | $0.00 |
| -减：资本性资产减值 | – | – | – | $0.00 | $0.00 |
| 终止经营净利润 | – | – | – | $0.00 | $0.00 |
| 其他优先股股息 | – | – | – | $0.00 | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $264.55M | $281.00M | $308.68M | $342.65M | $342.65M |
| 流动资产合计 | $187.23M | $205.37M | $240.33M | $277.47M | $277.47M |
| 现金及现金等价物与短期投资 | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| -现金及现金等价物 | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| 应收款 | $37.27M | $41.30M | $46.03M | $75.71M | $75.71M |
| -应收账款 | $37.27M | $41.30M | $46.03M | $75.71M | $75.71M |
| 存货 | $22.09M | $20.93M | $26.23M | $25.34M | $25.34M |
| 其他流动资产 | $7.09M | $7.30M | $8.29M | $10.30M | $10.30M |
| 非流动资产合计 | $77.32M | $75.63M | $68.35M | $65.18M | $65.18M |
| 固定资产净值 | $4.71M | $4.91M | $4.76M | $4.71M | $4.71M |
| -固定资产原值 | $29.35M | $29.21M | $28.62M | $28.21M | $28.21M |
| -累计折旧 | -$24.64M | -$24.30M | -$23.86M | -$23.50M | -$23.50M |
| 商誉及其他无形资产 | $30.56M | $31.53M | $32.58M | $33.60M | $33.60M |
| -商誉 | $19.44M | $19.44M | $19.44M | $19.44M | $19.44M |
| -其他无形资产 | $11.12M | $12.09M | $13.14M | $14.16M | $14.16M |
| 一年以上递延资产 | $29.22M | $27.30M | $24.13M | $19.60M | $19.60M |
| 其他非流动资产 | $12.83M | $11.90M | $6.89M | $7.27M | $7.27M |
| 负债合计 | $53.47M | $65.00M | $65.74M | $86.11M | $86.11M |
| 流动负债合计 | $43.03M | $38.50M | $44.55M | $64.27M | $64.27M |
| 应付款 | $11.83M | $8.29M | $11.46M | $14.53M | $14.53M |
| -应付账款 | $11.83M | $8.29M | $11.46M | $14.53M | $14.53M |
| 一年内应计费用 | $12.77M | $11.14M | $11.01M | $11.38M | $11.38M |
| 其他流动负债 | $3.19M | $4.39M | $6.05M | $5.79M | $5.79M |
| 非流动负债合计 | $10.44M | $26.50M | $21.19M | $21.84M | $21.84M |
| 其他非流动负债 | $10.44M | $10.79M | $5.10M | $5.37M | $5.37M |
| 股东权益合计 | $211.08M | $216.00M | $242.94M | $256.55M | $256.55M |
| 股东权益 | $211.08M | $216.00M | $242.94M | $256.55M | $256.55M |
| 股本 | $149,000.00 | $149,000.00 | $149,000.00 | $148,000.00 | $148,000.00 |
| -普通股 | $149,000.00 | $149,000.00 | $149,000.00 | $148,000.00 | $148,000.00 |
| 资本公积 | $300.86M | $297.09M | $296.33M | $299.08M | $299.08M |
| 留存收益 | -$77.06M | -$68.38M | -$53.54M | -$42.68M | -$42.68M |
| 减：库存股 | $12.86M | $12.86M | – | – | – |
| 短期债务及融资租赁负债 | – | $1.50M | $1.50M | $1.50M | $1.50M |
| -一年内到期债务 | – | $1.50M | $1.50M | $1.50M | $1.50M |
| 长期债务及融资租赁负债 | – | $15.71M | $16.09M | $16.47M | $16.47M |
| -长期债务 | – | $15.71M | $16.09M | $16.47M | $16.47M |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $3.92M | -$10.02M | $1.88M | $74.00M | $24.96M |
| 持续经营经营活动现金流净额 | $3.92M | -$10.02M | $1.88M | $74.00M | $24.96M |
| 持续经营净利润 | -$8.68M | -$14.84M | -$10.86M | $48.58M | $15.19M |
| 折旧、折耗与摊销 | $1.46M | $1.53M | $1.62M | $14.88M | $3.22M |
| 递延税款 | -$1.92M | -$3.17M | -$4.53M | $8.71M | $2.05M |
| 其他非现金项目 | $362,000.00 | $438,000.00 | $448,000.00 | $1.90M | $423,000.00 |
| 营运资金变动 | $8.66M | -$160,000.00 | $15.44M | -$22.98M | -$1.76M |
| -应收款变动 | $1.76M | -$545,000.00 | $28.21M | -$26.39M | -$887,000.00 |
| -存货变动 | -$1.16M | $5.30M | -$889,000.00 | -$1.53M | $1.16M |
| -应付账款及应计费用变动 | $7.76M | -$4.30M | -$14.15M | $13.48M | $388,000.00 |
| -其他流动资产变动 | $453,000.00 | $1.27M | $2.01M | -$8.82M | -$3.89M |
| 投资活动现金流净额 | -$193,000.00 | -$635,000.00 | -$5.64M | -$6.89M | -$335,000.00 |
| 持续经营投资活动现金流净额 | -$193,000.00 | -$635,000.00 | -$5.64M | -$6.89M | -$335,000.00 |
| 固定资产购置及出售净额 | -$166,000.00 | -$598,000.00 | -$570,000.00 | -$1.03M | -$285,000.00 |
| 无形资产购置及出售净额 | -$4.89M | – | – | – | – |
| 筹资活动现金流 | -$18.77M | -$13.28M | -$2.59M | -$5.41M | -$583,000.00 |
| 持续经营筹资活动现金流净额 | -$18.77M | -$13.28M | -$2.59M | -$5.41M | -$583,000.00 |
| 债务发行及偿还净额 | -$17.25M | -$375,000.00 | -$375,000.00 | -$1.00M | -$250,000.00 |
| 普通股发行净额 | -$372,000.00 | -$12.60M | -$1.90M | -$3.12M | -$51,000.00 |
| 其他筹资费用净额 | -$1.15M | -$314,000.00 | -$309,000.00 | -$1.29M | -$282,000.00 |
| 期末现金余额 | $120.79M | $135.84M | $159.77M | $166.12M | $166.12M |
| 现金净变动 | -$15.05M | -$23.93M | -$6.35M | $61.71M | $24.04M |
| 期初现金余额 | $135.84M | $159.77M | $166.12M | $104.42M | $142.08M |
| 自由现金流 | -$1.14M | -$10.72M | $1.31M | $72.97M | $28.44M |
| 业务购买及出售净额 | – | $0.00 | -$5.00M | -$3.76M | – |
| -其他营运资金变动 | – | – | $250,000.00 | $289,000.00 | $1.47M |
| 其他投资变动净额 | – | – | -$72,000.00 | -$2.09M | -$50,000.00 |
| 终止经营经营活动现金流 | – | – | – | $0.00 | $0.00 |
| 优先股发行净额 | – | – | – | $0.00 | – |
| 股票期权行使所得 | – | – | – | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 MDXG。
登录后参与讨论。